Journal of Clinical Medicine

Research

15 pages, 1543 KiB

Open AccessArticle

Speech Perception Changes in the Acoustically Aided, Nonimplanted Ear after Cochlear Implantation: A Multicenter Study

by Mario A. Svirsky, Arlene C. Neuman, Jonathan D. Neukam, Annette Lavender, Margaret K. Miller, Ksenia A. Aaron, Piotr H. Skarzynski, Katarzyna B. Cywka, Henryk Skarzynski, Eric Truy, Fabien Seldran, Ruben Hermann, Paul Govaerts, Geert De Ceulaer, Francois Bergeron, Matthieu Hotton, Michelle Moran, Richard C. Dowell, Maria Valeria Schmidt Goffi-Gomez, Ana Tereza de Matos Magalhães, Rosamaria Santarelli and Pietro Scimemi Show full author list Hide full author list

J. Clin. Med. 2020, 9(6), 1758; https://doi.org/10.3390/jcm9061758 - 5 Jun 2020

Cited by 2 | Viewed by 3340

Abstract

In recent years there has been an increasing percentage of cochlear implant (CI) users who have usable residual hearing in the contralateral, nonimplanted ear, typically aided by acoustic amplification. This raises the issue of the extent to which the signal presented through the [...] Read more.

In recent years there has been an increasing percentage of cochlear implant (CI) users who have usable residual hearing in the contralateral, nonimplanted ear, typically aided by acoustic amplification. This raises the issue of the extent to which the signal presented through the cochlear implant may influence how listeners process information in the acoustically stimulated ear. This multicenter retrospective study examined pre- to postoperative changes in speech perception in the nonimplanted ear, the implanted ear, and both together. Results in the latter two conditions showed the expected increases, but speech perception in the nonimplanted ear showed a modest yet meaningful decrease that could not be completely explained by changes in unaided thresholds, hearing aid malfunction, or several other demographic variables. Decreases in speech perception in the nonimplanted ear were more likely in individuals who had better levels of speech perception in the implanted ear, and in those who had better speech perception in the implanted than in the nonimplanted ear. This raises the possibility that, in some cases, bimodal listeners may rely on the higher quality signal provided by the implant and may disregard or even neglect the input provided by the nonimplanted ear. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

15 pages, 1752 KiB

Open AccessArticle

Biocompatibility of Bone Marrow-Derived Mesenchymal Stem Cells in the Rat Inner Ear following Trans-Tympanic Administration

by Adrien A. Eshraghi, Emre Ocak, Angela Zhu, Jeenu Mittal, Camron Davies, David Shahal, Erdogan Bulut, Rahul Sinha, Viraj Shah, Mario M. Perdomo and Rahul Mittal

J. Clin. Med. 2020, 9(6), 1711; https://doi.org/10.3390/jcm9061711 - 2 Jun 2020

Cited by 10 | Viewed by 3179

Abstract

Recent advancements in stem cell therapy have led to an increased interest within the auditory community in exploring the potential of mesenchymal stem cells (MSCs) in the treatment of inner ear disorders. However, the biocompatibility of MSCs with the inner ear, especially when [...] Read more.

Recent advancements in stem cell therapy have led to an increased interest within the auditory community in exploring the potential of mesenchymal stem cells (MSCs) in the treatment of inner ear disorders. However, the biocompatibility of MSCs with the inner ear, especially when delivered non-surgically and in the immunocompetent cochlea, is not completely understood. In this study, we determined the effect of intratympanic administration of rodent bone marrow MSCs (BM-MSCs) on the inner ear in an immunocompetent rat model. The administration of MSCs did not lead to the generation of any oxidative stress in the rat inner ear. There was no significant production of proinflammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6 and IL-12, due to BM-MSCs administration into the rat cochlea. BM-MSCs do not activate caspase 3 pathway, which plays a central role in sensory cell damage. Additionally, transferase dUTP nick end labeling (TUNEL) staining determined that there was no significant cell death associated with the administration of BM-MSCs. The results of the present study suggest that trans-tympanic administration of BM-MSCs does not result in oxidative stress or inflammatory response in the immunocompetent rat cochlea. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
Oxidative stress determination: The levels of 8-isoprostane as a marker of oxidative stress was determined in whole cochlear tissue homogenates by ELISA at 3, 5, 7, 14, and 30 days post-administration. There was no statistically significant difference in 8-isoprostane levels in cochleae harvested from rats that received bone marrow mesenchymal stem cells (BM-MSCs), phosphate buffered saline (PBS) injected, or control group. Full article ">Figure 2
Cleaved caspase 3 immunostaining: (A) Rat cochlear slices were subjected to cleaved caspase 3 immunostaining (red) to determine apoptosis. Cell nuclei were stained with DAPI (blue). Cochleae harvested from rats that received BM-MSCs, PBS injected, or control group showed no or sparse staining whereas those from the positive group showed intense staining (red color). Blue color shows DAPI staining. (B) Mean signal intensity for cleaved caspase 3 was calculated using Image J software. Data are expressed as mean values ± standard deviation (SD). WC: whole cochlea; SGNs: Spiral Ganglion Neurons; HCs: Hair Cells; SL: Spiral Ligament. Full article ">Figure 3
Proinflammatory cytokines: The levels of proinflammatory cytokines, tumor necrosis factor (TNF)-α (A), interleukin (IL)-1β (B), IL-6 (C) and IL-12 (D) were determined in cochlear homogenates by ELISA. Data are expressed as mean values ± SD. Full article ">Figure 4
Transferase dUTP nick end labeling (TUNEL) staining: Rat cochlear slices were subjected to TUNEL immunostaining to determine cell death. (A) Cochleae harvested from rats that received BM-MSCs, PBS injected, or control group showed no or sparse staining whereas those from positive group showed intense staining (red color). Blue color shows DAPI staining. (B) The percentage of TUNEL positive cells were calculated and graphed. Arrows indicate cell death in positive control group. WC: whole cochlea; SGNs: Spiral Ganglion Neurons; HCs: Hair Cells; SL: Spiral Ligament. Full article ">

18 pages, 1190 KiB

Open AccessArticle

Listening in Noise Remains a Significant Challenge for Cochlear Implant Users: Evidence from Early Deafened and Those with Progressive Hearing Loss Compared to Peers with Normal Hearing

by Yael Zaltz, Yossi Bugannim, Doreen Zechoval, Liat Kishon-Rabin and Ronen Perez

J. Clin. Med. 2020, 9(5), 1381; https://doi.org/10.3390/jcm9051381 - 8 May 2020

Cited by 27 | Viewed by 3955

Abstract

Cochlear implants (CIs) are the state-of-the-art therapy for individuals with severe to profound hearing loss, providing them with good functional hearing. Nevertheless, speech understanding in background noise remains a significant challenge. The purposes of this study were to: (1) conduct a novel within-study [...] Read more.

Cochlear implants (CIs) are the state-of-the-art therapy for individuals with severe to profound hearing loss, providing them with good functional hearing. Nevertheless, speech understanding in background noise remains a significant challenge. The purposes of this study were to: (1) conduct a novel within-study comparison of speech-in-noise performance across ages in different populations of CI and normal hearing (NH) listeners using an adaptive sentence-in-noise test, and (2) examine the relative contribution of sensory information and cognitive–linguistic factors to performance. Forty CI users (mean age 20 years) were divided into “early-implanted” <4 years (n = 16) and “late-implanted” >6 years (n = 11), all prelingually deafened, and “progressively deafened” (n = 13). The control group comprised 136 NH subjects (80 children, 56 adults). Testing included the Hebrew Matrix test, word recognition in quiet, and linguistic and cognitive tests. Results show poorer performance in noise for CI users across populations and ages compared to NH peers, and age at implantation and word recognition in quiet were found to be contributing factors. For those recognizing 50% or more of the words in quiet (n = 27), non-verbal intelligence and receptive vocabulary explained 63% of the variance in noise. This information helps delineate the relative contribution of top-down and bottom-up skills for speech recognition in noise and can help set expectations in CI counseling. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
Individual speech reception thresholds in noise (SRTn) of the Hebrew Matrix sentence-in-noise test (mean signal-to-noise ratio (SNR) in measurements 3, 4) for early-implanted cochlear implants (CI) users (n = 16, seven implanted before two years of age), progressive CI users (n = 13), late-implanted CI users (n = 11), and normal hearing (NH) controls (n = 136). Mean performance of the NH ±1 standard deviation is shown between the gray lines. Full article ">Figure 2
Box-and-whisker plot of the SRTn of the Hebrew Matrix sentence-in-noise test (mean SNR in measurements 3, 4) for early-implanted CI users (n = 16), progressive CI users (n = 13), late-implanted CI users (n = 11), and NH controls (children: n = 80, adults: 56). Also shown are the individual results of the children (empty circles) and adult (empty triangles) CI users. Note that within the “early-implanted” CI group, the children were implanted before two years of age. Full article ">Figure 3
Box-and-whisker plot of the results in the Hebrew Arthur Boothroyd (AB) consonant–vowel–consonant (CVC) words in quiet (HAB) test for the early-implanted (n = 16), progressive (n = 13), and late-implanted (n = 10) CI users. Full article ">Figure 4
Individual results in the Hebrew CVC words in quiet (HAB) test versus SRTn of the Hebrew Matrix sentence-in-noise test (mean SNR in measurements 3, 4), for the early-implanted (n = 16), progressive (n = 13), and late-implanted (n = 10) CI users. Full article ">Figure 5
Individual scores in the (a) phonemic and (b) semantic fluency tests for the Q50 performers (CI users who scored ≥50% in the words-in-quiet test) compared to NH performance (shown between the broken lines: mean ± Standard deviation by age) from Kave and Knafo-Noam [<a href="#B72-jcm-09-01381" class="html-bibr">72</a>]. Full article ">

12 pages, 1868 KiB

Open AccessArticle

Evaluating the Efficacy of L-N-acetylcysteine and Dexamethasone in Combination to Provide Otoprotection for Electrode Insertion Trauma

by Adrien A. Eshraghi, David Shahal, Camron Davies, Jeenu Mittal, Viraj Shah, Erdogan Bulut, Carolyn Garnham, Priyanka Sinha, Dibyanshi Mishra, Hannah Marwede and Rahul Mittal

J. Clin. Med. 2020, 9(3), 716; https://doi.org/10.3390/jcm9030716 - 6 Mar 2020

Cited by 6 | Viewed by 3552

Abstract

Background: Electrode insertion trauma (EIT) during cochlear implantation (CI) can cause loss of residual hearing. L-N-acetylcysteine (L-NAC) and dexamethasone (Dex) have been individually shown to provide otoprotection albeit at higher concentrations that may be associated with adverse effects. Objective/Aims: The aim of this [...] Read more.

Background: Electrode insertion trauma (EIT) during cochlear implantation (CI) can cause loss of residual hearing. L-N-acetylcysteine (L-NAC) and dexamethasone (Dex) have been individually shown to provide otoprotection albeit at higher concentrations that may be associated with adverse effects. Objective/Aims: The aim of this study is to determine whether L-NAC and Dex could be combined to decrease their effective dosage. Materials and Methods: The organ of Corti (OC) explants were divided into various groups: 1) control; 2) EIT; 3) EIT treated with different concentrations of Dex; 4) EIT treated with different concentrations of L-NAC; 5) EIT treated with L-NAC and Dex in combination. Hair cell (HC) density, levels of oxidative stress, proinflammatory cytokines and nitric oxide (NO) was determined. Results: There was a significant loss of HCs in explants subjected to EIT compared to the control group. L-NAC and Dex in combination was able to provide significant otoprotection at lower concentrations compared to individual drugs. Conclusions and Significance: A combination containing L-NAC and Dex is effective in protecting sensory cells at lower protective doses than each compound separately. These compounds can be combined allowing a decrease of potential side effects of each compound and providing significant otoprotection for EIT. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
L-N-acetylcysteine (L-NAC) and dexamethasone (Dex) provides otoprotection against electrode insertion trauma (EIT). Organ of Corti (OC) explants were exposed to EIT alone or EIT and treated with L-NAC and Dex either individually or in combination. Samples were subjected to FITC-phalloidin staining to visualize hair cells (HCs). Results are representative of four independent experiments. Image represents middle + base area of explant. n = 9 OCs per group per experiment. Scale bars: 10 micrometers. Full article ">Figure 2
Hair cell quantification. Total hair cells (THCs) were counted based on FITC-phalloidin staining. EIT-exposed OC explants showed a significant decrease in the number of THC compared to control group. L-NAC and Dex in combination was able to significantly prevent EIT induced sensory cell loss at lower doses. Data are expressed as mean values ± SD and are representative of four independent experiments. * P < 0.05 or ** P < 0.001 compared to EIT group. n = 9 OCs per group per experiment. Full article ">Figure 3
Oxidative stress in OC explants. Mean signal intensity for CellROX was calculated using Image J software. Data are expressed as mean values ± SD and is representative of four independent experiments. * P < 0.05 or ** P < 0.001 compared to EIT group. n = 9 OCs per group per experiment. Full article ">Figure 4
Proinflammatory cytokines. The levels of TNF-α (A), IL-1β (B), and IL-6 (C) were determined in OC homogenates using ELISA kits. Data are expressed as mean values ± SD and are representative of four independent experiments. * P < 0.01 or ** P < 0.001 compared to EIT group. n = 9 OCs per group per experiment. Full article ">Figure 5
Nitric oxide (NO) levels in OC explants: NO production was determined in homogenates of OC explants. Data are expressed as mean values ± SD and are representative of three independent experiments. * P < 0.01 or ** P < 0.001 compared to EIT group. n = 9 OCs per group per experiment. Full article ">

23 pages, 481 KiB

Open AccessArticle

The Effect of Hearing Aid Use on Cognition in Older Adults: Can We Delay Decline or Even Improve Cognitive Function?

by Julia Sarant, David Harris, Peter Busby, Paul Maruff, Adrian Schembri, Ulrike Lemke and Stefan Launer

J. Clin. Med. 2020, 9(1), 254; https://doi.org/10.3390/jcm9010254 - 17 Jan 2020

Cited by 89 | Viewed by 39709

Abstract

Hearing loss is a modifiable risk factor for dementia in older adults. Whether hearing aid use can delay the onset of cognitive decline is unknown. Participants in this study (aged 62–82 years) were assessed before and 18 months after hearing aid fitting on [...] Read more.

Hearing loss is a modifiable risk factor for dementia in older adults. Whether hearing aid use can delay the onset of cognitive decline is unknown. Participants in this study (aged 62–82 years) were assessed before and 18 months after hearing aid fitting on hearing, cognitive function, speech perception, quality of life, physical activity, loneliness, isolation, mood, and medical health. At baseline, multiple linear regression showed hearing loss and age predicted significantly poorer executive function performance, while tertiary education predicted significantly higher executive function and visual learning performance. At 18 months after hearing aid fitting, speech perception in quiet, self-reported listening disability and quality of life had significantly improved. Group mean scores across the cognitive test battery showed no significant decline, and executive function significantly improved. Reliable Change Index scores also showed either clinically significant improvement or stability in executive function for 97.3% of participants, and for females for working memory, visual attention and visual learning. Relative stability and clinically and statistically significant improvement in cognition were seen in this participant group after 18 months of hearing aid use, suggesting that treatment of hearing loss with hearing aids may delay cognitive decline. Given the small sample size, further follow up is required. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

11 pages, 1298 KiB

Open AccessArticle

Cochlear Implantation Outcome in Children with DFNB1 locus Pathogenic Variants

by Dominika Oziębło, Anita Obrycka, Artur Lorens, Henryk Skarżyński and Monika Ołdak

J. Clin. Med. 2020, 9(1), 228; https://doi.org/10.3390/jcm9010228 - 15 Jan 2020

Cited by 12 | Viewed by 2919

Abstract

Almost 60% of children with profound prelingual hearing loss (HL) have a genetic determinant of deafness, most frequently two DFNB1 locus (GJB2/GJB6 genes) recessive pathogenic variants. Only few studies combine HL etiology with cochlear implantation (CI) outcome. Patients with profound prelingual HL [...] Read more.

Almost 60% of children with profound prelingual hearing loss (HL) have a genetic determinant of deafness, most frequently two DFNB1 locus (GJB2/GJB6 genes) recessive pathogenic variants. Only few studies combine HL etiology with cochlear implantation (CI) outcome. Patients with profound prelingual HL who received a cochlear implant before 24 months of age and had completed DFNB1 genetic testing were enrolled in the study (n = 196). LittlEARS questionnaire scores were used to assess auditory development. Our data show that children with DFNB1-related HL (n = 149) had good outcome from the CI (6.85, 22.24, and 28 scores at 0, 5, and 9 months post-CI, respectively). A better auditory development was achieved in patients who receive cochlear implants before 12 months of age. Children without residual hearing presented a higher rate of auditory development than children with responses in hearing aids over a wide frequency range prior to CI, but both groups reached a similar level of auditory development after 9 months post-CI. Our data shed light upon the benefits of CI in the homogenous group of patients with HL due to DFNB1 locus pathogenic variants and clearly demonstrate that very early CI is the most effective treatment method in this group of patients. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
LEAQ scores at the time of cochlear implant activation. (A) Differences in LEAQ scores in patients with and without DFNB1 locus pathogenic variants; (B) differences in LEAQ scores in patients with minimal and wide responses provided by HAs; (C) differences in LEAQ scores in patients with very early and early CI. Whiskers represent 5–95 percentile, and black dots indicate outliers. Asterisks represent statistical significance, ***p < 0.001; ns, not significant. Full article ">Figure 2
Distribution of LEAQ scores at the time of cochlear implant activation in DFNB1 HL patients. Full article ">Figure 3
LEAQ scores in the fifth month after cochlear implantation. (A) Differences in LEAQ scores in patients with and without DFNB1 locus pathogenic variants; (B) differences in LEAQ scores in patients with minimal and wide responses provided by HAs; (C) differences in LEAQ scores in patients with very early and early CI. Whiskers represent 5–95 percentile and black dots indicate outliers. Asterisks represent statistical significance, * p < 0.05; ns, not significant. Full article ">Figure 4
Distribution of LEAQ scores in the fifth month after CI in DFNB1 HL patients. Full article ">Figure 5
Distribution of an average LEAQ score of patients with DFNB1 HL at subsequent time intervals (mean ± 95% confidence interval). Asterisks indicate statistically significant differences observed between patients with minimal HAs responses and very early CI vs. patients with wide HAs responses and early CI. Asterisks represent statistical significance, * p < 0.05, *** p < 0.001. Full article ">

8 pages, 1365 KiB

Open AccessArticle

Beware of a Fragile Footplate: Lessons from Ossiculoplasty in Patients with Ossicular Anomalies Related to Second Pharyngeal Arch Defects

by Sun A Han, Goun Choe, Yoonjoong Kim, Ja-Won Koo, Byung Yoon Choi and Jae-Jin Song

J. Clin. Med. 2019, 8(12), 2130; https://doi.org/10.3390/jcm8122130 - 3 Dec 2019

Cited by 8 | Viewed by 7922

Abstract

Background and objectives: We review the intraoperative findings and postoperative outcomes of ossiculoplasty in subjects with second pharyngeal arch (SPA)-derived ossicular anomalies. We summarize potential intraoperative complications and recommend precautions that may reduce the risk of fracture. Materials and Methods: Twenty-four patients with [...] Read more.

Background and objectives: We review the intraoperative findings and postoperative outcomes of ossiculoplasty in subjects with second pharyngeal arch (SPA)-derived ossicular anomalies. We summarize potential intraoperative complications and recommend precautions that may reduce the risk of fracture. Materials and Methods: Twenty-four patients with SPA-derived ossicular anomalies were included, and pre- and postoperative audiometric results were compared. Results: The mean air conduction threshold (56.0 ± 12.4 dB HL) was significantly improved 1 month (27.6 ± 10.1 dB HL) and 6 months (23.8 ± 13.2 dB HL) after surgery (p < 0.001). The preoperative air–bone gap (ABG) (40.4 ± 7.4 dB HL) was significantly decreased at 1 month (15.1 ± 5.9 dB HL) and 6 months (11.3 ± 8.9 dB HL) postoperation. ABG closure was successful (<20 dB HL) in 21 (87.5%) patients 6 months after surgery. Intraoperative footplate fractures occurred in 3 of 24 patients. The fractures were managed successfully, and the ABG closure was successful in all cases. Conclusions: The stapes footplate is likely to be relatively thin in subjects with SPA-derived ossicular anomalies because the footplate is partially or totally derived from the SPA. Thus, a fragile footplate should be expected, and care is needed when handling the footplate. However, when complications are overcome, the audiological outcomes are excellent in most cases. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Graphical abstract

17 pages, 2030 KiB

Open AccessArticle

Solid Lipid Nanoparticles Loaded with Glucocorticoids Protect Auditory Cells from Cisplatin-Induced Ototoxicity

by Blanca Cervantes, Lide Arana, Silvia Murillo-Cuesta, Marina Bruno, Itziar Alkorta and Isabel Varela-Nieto

J. Clin. Med. 2019, 8(9), 1464; https://doi.org/10.3390/jcm8091464 - 14 Sep 2019

Cited by 38 | Viewed by 4991

Abstract

Cisplatin is a chemotherapeutic agent that causes the irreversible death of auditory sensory cells, leading to hearing loss. Local administration of cytoprotective drugs is a potentially better option co-therapy for cisplatin, but there are strong limitations due to the difficulty of accessing the [...] Read more.

Cisplatin is a chemotherapeutic agent that causes the irreversible death of auditory sensory cells, leading to hearing loss. Local administration of cytoprotective drugs is a potentially better option co-therapy for cisplatin, but there are strong limitations due to the difficulty of accessing the inner ear. The use of nanocarriers for the efficient delivery of drugs to auditory cells is a novel approach for this problem. Solid lipid nanoparticles (SLNs) are biodegradable and biocompatible nanocarriers with low solubility in aqueous media. We show here that stearic acid-based SLNs have the adequate particle size, polydispersity index and ζ-potential, to be considered optimal nanocarriers for drug delivery. Stearic acid-based SLNs were loaded with the fluorescent probe rhodamine to show that they are efficiently incorporated by auditory HEI-OC1 (House Ear Institute-Organ of Corti 1) cells. SLNs were not ototoxic over a wide dose range. Glucocorticoids are used to decrease cisplatin-induced ototoxicity. Therefore, to test SLNs’ drug delivery efficiency, dexamethasone and hydrocortisone were tested either alone or loaded into SLNs and tested in a cisplatin-induced ototoxicity in vitro assay. Our results indicate that the encapsulation in SLNs increases the protective effect of low doses of hydrocortisone and lengthens the survival of HEI-OC1 cells treated with cisplatin. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Graphical abstract

12 pages, 890 KiB

Open AccessArticle

“Third Window” and “Single Window” Effects Impede Surgical Success: Analysis of Retrofenestral Otosclerosis Involving the Internal Auditory Canal or Round Window

by Yun Jung Bae, Ye Ji Shim, Byung Se Choi, Jae-Hyoung Kim, Ja-Won Koo and Jae-Jin Song

J. Clin. Med. 2019, 8(8), 1182; https://doi.org/10.3390/jcm8081182 - 7 Aug 2019

Cited by 10 | Viewed by 4753

Abstract

Background and Objectives: We aimed to identify prognostic computed tomography (CT) findings in retrofenestral otosclerosis, with particular attention paid to the role of otosclerotic lesion area in predicting post-stapedotomy outcome. Materials and Methods: We included 17 subjects (23 ears) with retrofenestral otosclerosis who [...] Read more.

Background and Objectives: We aimed to identify prognostic computed tomography (CT) findings in retrofenestral otosclerosis, with particular attention paid to the role of otosclerotic lesion area in predicting post-stapedotomy outcome. Materials and Methods: We included 17 subjects (23 ears) with retrofenestral otosclerosis who underwent stapedotomy. On preoperative CT, the presence of cavitating lesion and involvement of various subsites (cochlea, round window [RW], vestibule, and semicircular canal) were assessed. Pre- and post-stapedotomy audiometric results were compared according to the CT findings. The surgical outcomes were analyzed using logistic regression with Firth correction. Results: Cavitating lesions were present in 15 of 23 ears (65.2%). Involvement of the RW was the strongest predictor of unsuccessful surgical outcome, followed by involvement of the internal auditory canal (IAC) and the cochlea. Conclusions: RW and IAC involvement in retrofenestral otosclerosis were shown to predict unsuccessful outcomes. While a “third window” effect caused by extension of a cavitating lesion into the IAC may dissipate sound energy and thus serve as a barrier to desirable postoperative audiological outcome, a “single window” effect due to an extension of retrofenestral otosclerosis into the RW may preclude a good surgical outcome, even after successful stapedotomy, due to less compressible cochlear fluid and thus decreased linear movement of the piston. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Review

Jump to: Research, Other

27 pages, 3658 KiB

Open AccessReview

Inner Ear Gene Therapies Take Off: Current Promises and Future Challenges

by Sedigheh Delmaghani and Aziz El-Amraoui

J. Clin. Med. 2020, 9(7), 2309; https://doi.org/10.3390/jcm9072309 - 21 Jul 2020

Cited by 79 | Viewed by 12223

Abstract

Hearing impairment is the most frequent sensory deficit in humans of all age groups, from children (1/500) to the elderly (more than 50% of the over-75 s). Over 50% of congenital deafness are hereditary in nature. The other major causes of deafness, which [...] Read more.

Hearing impairment is the most frequent sensory deficit in humans of all age groups, from children (1/500) to the elderly (more than 50% of the over-75 s). Over 50% of congenital deafness are hereditary in nature. The other major causes of deafness, which also may have genetic predisposition, are aging, acoustic trauma, ototoxic drugs such as aminoglycosides, and noise exposure. Over the last two decades, the study of inherited deafness forms and related animal models has been instrumental in deciphering the molecular, cellular, and physiological mechanisms of disease. However, there is still no curative treatment for sensorineural deafness. Hearing loss is currently palliated by rehabilitation methods: conventional hearing aids, and for more severe forms, cochlear implants. Efforts are continuing to improve these devices to help users to understand speech in noisy environments and to appreciate music. However, neither approach can mediate a full recovery of hearing sensitivity and/or restoration of the native inner ear sensory epithelia. New therapeutic approaches based on gene transfer and gene editing tools are being developed in animal models. In this review, we focus on the successful restoration of auditory and vestibular functions in certain inner ear conditions, paving the way for future clinical applications. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
Mammalian inner ear anatomy and cochlear tonotopic organization. The mammalian inner ear consists of the vestibule (balance organs), which detect linear and angular accelerations, and the cochlea, the hearing organ, which detects sound waves. (A,B) The cochlea is made up of three fluid-filled compartments of differing ionic compositions—scala vestibuli (perilymph), the scala media (endolymph), and the scala tympani (perilymph). Sound conversion into electrical signals requires three major types of functional cells: hair cells (purple), supporting cells, and spiral ganglion neurons (yellow). (C) The auditory sensory organ, the organ of Corti, is made up of one row of highly organized inner hair cells (IHCs), three rows of outer hair cells (OHCs), flanked by various types of supporting cells. Along the cochlea, the hair cells, underlying basilar membrane (BM), surrounding, and overlying tectorial membrane (TM) are optimized to perceive specific and characteristic sound frequencies, defining a cochlear tonotopy that is preserved up to the auditory cortex. The structural and physical properties of the cochlea vary from base (shorter and stiffer cells) to apex (longer and more flexible cells). The cochlear base mainly perceives high-frequency tones (up to 20 kHz in humans), while the apex detects low-frequency sounds (20 Hz in humans). Scale bar in B, C: 1 μm. Full article ">Figure 2
Hearing loss causal origins and adapted therapeutic strategies. (A) Hearing loss, defined as mild (loss of 21 to 40 dB HL), moderate (41–70 dB HL loss), severe (71–90 dB HL loss), or profound (>90 dB HL loss), can be due to multiple causes: genetic, noise, and/or age. Whatever the cause, the hearing loss can start any time after birth, with varying degrees of progression and severity. (B) Various therapeutic approaches (gene supplementation, silencing, or gene editing) are being implemented either to protect, prevent and/or repair hearing loss, regenerate or replace inner ear cells. Full article ">Figure 3
Functional stratification genes/proteins causing human isolated deafness hearing loss. Based on their established role and characterization of corresponding animal models, the human deafness genes (DFNA DFNB DFNX AUNA) can be grouped into several functional categories: (1) hair bundle development and functioning, (2) synaptic transmission, (3) hair cell’s adhesion and maintenance, (4) cochlea ion homeostasis, (5) transmembrane or secreted proteins and extracellular matrix, (6) oxidative stress, metabolism and mitochondrial defects, and (7) transcriptional regulation. DFNAi (red) denotes autosomal-dominant forms of deafness with undefined locus number. The genes/loci in grey denote that they share several functional categories. More detailed information regarding the deafness causative genes are provided in <a href="#app1-jcm-09-02309" class="html-app">Table S1</a>. Full article ">Figure 4
Delivery approaches in the inner ear. Schematic representation of the human ear, illustrating methods used to deliver therapeutics into the inner ear. These include systemic (red) and middle ear (blue) indirect approaches, as well as endolymphatic sac delivery (light blue) and direct injections through different compartments of the inner ear (green): cochleostomy (scala media), vestibule (through utricle or semicircular canal), and cochlea (through round window membrane or oval window). Some pros and cons of each methods are highlighted in <a href="#app1-jcm-09-02309" class="html-app">Table S2</a>. Full article ">

29 pages, 6016 KiB

Open AccessReview

Auditory Neuropathy Spectrum Disorders: From Diagnosis to Treatment: Literature Review and Case Reports

by Romolo Daniele De Siati, Flora Rosenzweig, Guillaume Gersdorff, Anaïs Gregoire, Philippe Rombaux and Naïma Deggouj

J. Clin. Med. 2020, 9(4), 1074; https://doi.org/10.3390/jcm9041074 - 10 Apr 2020

Cited by 54 | Viewed by 16852

Abstract

Auditory neuropathy spectrum disorder (ANSD) refers to a range of hearing impairments characterized by deteriorated speech perception, despite relatively preserved pure-tone detection thresholds. Affected individuals usually present with abnormal auditory brainstem responses (ABRs), but normal otoacoustic emissions (OAEs). These electrophysiological characteristics have led [...] Read more.

Auditory neuropathy spectrum disorder (ANSD) refers to a range of hearing impairments characterized by deteriorated speech perception, despite relatively preserved pure-tone detection thresholds. Affected individuals usually present with abnormal auditory brainstem responses (ABRs), but normal otoacoustic emissions (OAEs). These electrophysiological characteristics have led to the hypothesis that ANSD may be caused by various dysfunctions at the cochlear inner hair cell (IHC) and spiral ganglion neuron (SGN) levels, while the activity of outer hair cells (OHCs) is preserved, resulting in discrepancies between pure-tone and speech comprehension thresholds. The exact prevalence of ANSD remains unknown; clinical findings show a large variability among subjects with hearing impairment ranging from mild to profound hearing loss. A wide range of prenatal and postnatal etiologies have been proposed. The study of genetics and of the implicated sites of lesion correlated with clinical findings have also led to a better understanding of the molecular mechanisms underlying the various forms of ANSD, and may guide clinicians in better screening, assessment and treatment of ANSD patients. Besides OAEs and ABRs, audiological assessment includes stapedial reflex measurements, supraliminal psychoacoustic tests, electrocochleography (ECochG), auditory steady-state responses (ASSRs) and cortical auditory evoked potentials (CAEPs). Hearing aids are indicated in the treatment of ANSD with mild to moderate hearing loss, whereas cochlear implantation is the first choice of treatment in case of profound hearing loss, especially in case of IHC presynaptic disorders, or in case of poor auditory outcomes with conventional hearing aids. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

13 pages, 7265 KiB

Open AccessReview

Hearing with One Ear: Consequences and Treatments for Profound Unilateral Hearing Loss

by Hillary A. Snapp and Sebastian A. Ausili

J. Clin. Med. 2020, 9(4), 1010; https://doi.org/10.3390/jcm9041010 - 3 Apr 2020

Cited by 44 | Viewed by 10574

Abstract

There is an increasing global recognition of the negative impact of hearing loss, and its association to many chronic health conditions. The deficits and disabilities associated with profound unilateral hearing loss, however, continue to be under-recognized and lack public awareness. Profound unilateral hearing [...] Read more.

There is an increasing global recognition of the negative impact of hearing loss, and its association to many chronic health conditions. The deficits and disabilities associated with profound unilateral hearing loss, however, continue to be under-recognized and lack public awareness. Profound unilateral hearing loss significantly impairs spatial hearing abilities, which is reliant on the complex interaction of monaural and binaural hearing cues. Unilaterally deafened listeners lose access to critical binaural hearing cues. Consequently, this leads to a reduced ability to understand speech in competing noise and to localize sounds. The functional deficits of profound unilateral hearing loss have a substantial impact on socialization, learning and work productivity. In recognition of this, rehabilitative solutions such as the rerouting of signal and hearing implants are on the rise. This review focuses on the latest insights into the deficits of profound unilateral hearing impairment, and current treatment approaches. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
(A) An illustration of the acoustic head-shadow and the principle of time-delay between the two ears, dependent on the sound source. (B) Right and left temporal signals arriving from a right-leading sound source location. The ILD and ITD are illustrated on the amplitude and temporal domains, respectively. (C) The frequency and azimuth dependencies of the head and pinnae filter are shown. As the sound source moves from the hearing side (positive azimuth angles) to the deaf side (negative azimuth angles), the acoustic barrier created by the head attenuates high frequency signals contralateral to the source. Pinna gains are also observed for some frequencies at the ear ipsilateral to the source. (D) An illustration of the monaural spectral-pinnae cues as a function of the vertical position (elevation) of the sound source. The black arrows indicate the position-dependent frequency notch. Full article ">Figure 2
Comparison of the head-shadow and pinnae filtering for the words (A) ”Hat” and (B) “Sat” when presented at the deaf side. Spectrograms and sound waveforms (in gray) of the speech stimuli are shown for five corresponding azimuth positions. High frequency speech components are attenuated on the hearing side, erasing the unique informational marks that differentiate the words from each other. Full article ">Figure 3
An illustration of spatial hearing abilities for (A) normal hearing and (B) single-sided deaf listeners. Normal hearing listeners localize target sounds accurately and precisely along the horizontal (azimuth) and vertical (elevation) planes. Monaural hearing listeners, instead, can localize target sounds mainly in the hemifield of the hearing ear, with impaired performance on the contralateral deaf side. Full article ">Figure 4
Actual treatment solutions for profound unilateral hearing loss. Rerouting devices transmit the captured sound on the deaf side to the hearing ear (monaural input). In contralateral routing of signal (CROS) hearing aids, the transmitter wirelessly communicates to the contralateral hearing aid. Bone conduction devices transfer the sounds via transcranial skull vibrations towards the functional cochlea. The cochlear implant provides electrical stimulation directly to the deaf ear, preserving the contralateral acoustic hearing (bilateral input). Full article ">

20 pages, 1369 KiB

Open AccessReview

Research Insights on Neural Effects of Auditory Deprivation and Restoration in Unilateral Hearing Loss: A Systematic Review

by Jolijn Vanderauwera, Elisabeth Hellemans and Nicolas Verhaert

J. Clin. Med. 2020, 9(3), 812; https://doi.org/10.3390/jcm9030812 - 17 Mar 2020

Cited by 31 | Viewed by 6109

Abstract

Neuroplasticity following bilateral deafness and auditory restoration has been repeatedly investigated. In clinical practice, however, a significant number of patients present a severe-to-profound unilateral hearing loss (UHL). To date, less is known about the neuroplasticity following monaural hearing deprivation and auditory input restoration. [...] Read more.

Neuroplasticity following bilateral deafness and auditory restoration has been repeatedly investigated. In clinical practice, however, a significant number of patients present a severe-to-profound unilateral hearing loss (UHL). To date, less is known about the neuroplasticity following monaural hearing deprivation and auditory input restoration. This article provides an overview of the current research insights on the impact of UHL on the brain and the effect of auditory input restoration with a cochlear implant (CI). An exhaustive systematic review of the literature was performed selecting 38 studies that apply different neural analyses techniques. The main results show that the hearing ear becomes functionally dominant after monaural deprivation, reshaping the lateralization of the neural network for auditory processing, a process that can be considered to influence auditory restoration. Furthermore, animal models predict that the onset time of UHL impacts auditory restoration. Hence, the results seem to advocate for early restoration of UHL, although further research is required to disambiguate the effects of duration and onset of UHL on auditory restoration and on structural neuroplasticity following UHL deprivation and restoration. Ongoing developments on CI devices compatible with Magnetic Resonance Imaging (MRI) examinations will provide a unique opportunity to investigate structural and functional neuroplasticity following CI restoration more directly. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

12 pages, 247 KiB

Open AccessReview

Does Treating Hearing Loss in Older Adults Improve Cognitive Outcomes? A Review

by Hélène Amieva and Camille Ouvrard

J. Clin. Med. 2020, 9(3), 805; https://doi.org/10.3390/jcm9030805 - 16 Mar 2020

Cited by 49 | Viewed by 8326

Abstract

Hearing loss is the third most prevalent health condition in older age. In recent years, research has consistently reported an association between hearing loss and mental health outcomes, including poorer cognitive performances. Whether treating hearing loss in elders improves cognition has been directly [...] Read more.

Hearing loss is the third most prevalent health condition in older age. In recent years, research has consistently reported an association between hearing loss and mental health outcomes, including poorer cognitive performances. Whether treating hearing loss in elders improves cognition has been directly or indirectly addressed by several studies. This review aims at providing a synthesis of those results. Regarding the literature on hearing aids’ use and cognition, although the lack of interventional studies has to be underlined, observational data suggest that hearing aids positively impact long-term cognition, even though more research is necessary to ascertain this statement and provide information on the length or frequency of use required in order to observe benefits. Regarding cochlear implants in elders experiencing more severe auditory deprivation, the literature is scarcer. The available studies have many limitations and do not allow the drawing of clear conclusions. Taken together, the results are encouraging. Nevertheless, because hearing loss is suspected to account for 9% of dementia cases, and also because hearing loss is one of the few potentially modifiable factors from a dementia prevention perspective, the need to stimulate research to have clearer knowledge of the benefits of treating hearing loss on cognitive outcomes is urgent. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

21 pages, 4157 KiB

Open AccessReview

rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application

by Fabian Blanc, Michel Mondain, Alexis-Pierre Bemelmans, Corentin Affortit, Jean-Luc Puel and Jing Wang

J. Clin. Med. 2020, 9(2), 589; https://doi.org/10.3390/jcm9020589 - 21 Feb 2020

Cited by 13 | Viewed by 6809

Abstract

Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used to [...] Read more.

Over the last decade, pioneering molecular gene therapy for inner-ear disorders have achieved experimental hearing improvements after a single local or systemic injection of adeno-associated, virus-derived vectors (rAAV for recombinant AAV) encoding an extra copy of a normal gene, or ribozymes used to modify a genome. These results hold promise for treating congenital or later-onset hearing loss resulting from monogenic disorders with gene therapy approaches in patients. In this review, we summarize the current state of rAAV-mediated inner-ear gene therapies including the choice of vectors and delivery routes, and discuss the prospects and obstacles for the future development of efficient clinical rAAV-mediated cochlear gene medicine therapy. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
Inner ear anatomy and barriers. A: A schematic drawing of the structures of middle and inner ears, and inner-ear fluid flow and barriers. The tympanic membrane (TM) separates the external auditory canal from the middle ear that communicates with the nasopharynx via the Eustachian tube. The ossicular chain links the TM to the oval window (OW). Both round window (RW) and OW membranes form the connection between the middle ear and the cochlear perilymphatic space. The yellow arrows indicate communications between the perilymphatic spaces of the inner ear and the surrounding structures. B: Cross section of a single cochlear turn. The cochlea is made up of three canals: scala vestibuli (SV) and scala tympani (ST), filled with perilymph (in white), and scala media (SM), filled with endolymph (in blue). The red box indicates the organ of Corti. C: Shown is the organ of Corti. The organ of Corti located on the basilar membrane (in pink) is composed of mechanosensory cells, with three rows of outer hair cells (OHC) and one row of inner hair cells (IHC). Separating these hair cells are supporting cells (SCs). The nerve fibers (shown in green, nf) of the spiral ganglion neurons connect to sensory hair cells. Full article ">Figure 2
Schematic illustration of main administration routes tested in mice and potential suitable routes for human applications. The vectors can be delivered locally into the perilymph through the scala tympani (ST), trans-round-window (RW) membrane, or an oval-window (OW)/trans-stapedial injection into the endolymph through the scala media (SM) injection, canalostomy (C) or endolymphatic sac (ES) injection, and systemically through intravenous injection. The gray and white colors indicate the endolymphatic and perilymphatic spaces in the inner ear, respectively. The blue and green syringes indicate the main routes of administration tested in mice and the green and yellow syringes indicate the potential ones suitable for human applications. SV: scala vestibuli. Amp: ampulla. Full article ">

22 pages, 2356 KiB

Open AccessReview

Presbycusis: An Update on Cochlear Mechanisms and Therapies

by Jing Wang and Jean-Luc Puel

J. Clin. Med. 2020, 9(1), 218; https://doi.org/10.3390/jcm9010218 - 14 Jan 2020

Cited by 132 | Viewed by 19592

Abstract

Age-related hearing impairment (ARHI), also referred to as presbycusis, is the most common sensory impairment seen in the elderly. As our cochlea, the peripheral organ of hearing, ages, we tend to experience a decline in hearing and are at greater risk of cochlear [...] Read more.

Age-related hearing impairment (ARHI), also referred to as presbycusis, is the most common sensory impairment seen in the elderly. As our cochlea, the peripheral organ of hearing, ages, we tend to experience a decline in hearing and are at greater risk of cochlear sensory-neural cell degeneration and exacerbated age-related hearing impairments, e.g., gradual hearing loss, deterioration in speech comprehension (especially in noisy environments), difficulty in the localization sound sources, and ringing sensations in the ears. However, the aging process does not affect people uniformly; nor, in fact, does the aging process appear to be uniform even within an individual. Here, we outline recent research into chronological cochlear age in healthy people, and exacerbated hearing impairments during aging due to both extrinsic factors including noise and ototoxic medication, and intrinsic factors such as genetic predisposition, epigenetic factors, and aging. We review our current understanding of molecular pathways mediating ARHL and discuss recent discoveries in experimental hearing restoration and future prospects. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Figure 1
Inner-ear anatomy. (A) Schematic representation of ear anatomy. The ear is divided into three parts (insert): the external and middle ear transfer the sound waves to the inner ear where they are transduced into neural activity. The external ear is closed off from the middle ear by the eardrum. In the middle ear, the eardrum is mechanically linked, by a chain of three tiny bones (the ossicles), to the oval-window membrane which closes the inner ear. Embedded in the temporal bone, the inner ear comprises the balance organ or vestibule, and the hearing organ or cochlea. (B) Scanning electron micrograph of the organ of Corti. The cochlea is a coiled organ that forms a spiral. Scanning electron micrographs show a narrow, linear shape of IHC stereocilial bundles and a V-shape of OHC stereocilia. (C) Transverse section of the basal cochlear turn under light microscopy. The cochlea is made up of three canals wrapped around a bony axis, the modiolus. These canals are the scala tympani (ST), the scala vestibuli (SV), and the scala media (SM). The ST and SV are filled with perilymph. The SM is filled with endolymph. The organ of Corti is situated on the basilar membrane (bm). (B) = 2 mm, (C) = 10 µM, (D) = 50 µm. IHCs: inner hair cells; OHCs: outer hair cells ((B–D) micrographs courtesy of Marc Lenoir, Inserm U1051, France). Full article ">Figure 2
Age-related hearing loss according to the International Organization for Standardization (ISO) 7029 standard. Shown are audiograms for females (A) and males (B). The x-axis displays the pure tone frequency (Hz) and the y-axis the hearing thresholds (dB HL). Each individual graph is representative of the median audiogram at a particular age (ranging from 20 to 70 years old, with increments of 10 years). Full article ">Figure 3
Imbalance between anti-aging and pro-aging mechanisms with age. The scheme drawing numerates several anti-aging and pro-aging mechanisms identified in the cochlear aging process. Anti-aging mechanisms include estrogen, autophagic damage clearance, and mitochondrial dynamic. Pro-aging mechanisms include oxidative stress, DNA damage, mitochondrial dysfunction, senescence-like phenotype, and senescence-associated inflammation. During the aging process, decreased activity of anti-aging molecules and increased activity of pro-aging properties might lead to accumulation of mutations in mitochondrial DNA, increased lysosomal pH with a resulting accumulation of lipofuscin and aggregates, and nuclear DNA damage, leading to cochlear cell degeneration and age-related hearing loss. Full article ">Figure 4
Functional and morphological assessments in SAMP8 and in SAMR1 mice. (A) Functional assessment. The compound action potential (CAP) threshold (red line) and distortion product otoacoustic emissions (DPOAE) amplitude (blue line) evoked by 20 kHz tone bursts, and endocochlear potential (EP) recordings (orange line, right axis)) in SAMR1 and SAMP8 mice. Fifty SAMP8 mice (n = 10 per age: 1, 3, 6, 12, 18 months) and 60 SAMR1 (n = 10 per age: 1, 3, 6, 12, 18, 24 months) mice were used for functional assessment. The lifespan of SAMR1 and SAMP8 was approximately 30 and 20 months, respectively. Note the earlier and faster increase in CAP threshold and decrease in DPOAE amplitude and EP value (arrowheads indicated broken-stick nonlinearities) in the SAMP8. In contrast to SAMR1, no CAP threshold nor DPOAEs could be recorded in 12-month-old SAMP8 mice, respectively. (B) Morphological assessment. Age-related loss of inner hair cells (IHCs, red line), outer hair cells (OHCs, blue line), and spiral ganglion neurons (SGNs, green line, right axis). At the end of the functional assessment period, the cochleae were removed and prepared for hair cell counting using SEM (n = 5 per age per strain) and SNG using light microscopy (n = 5 per age per strain). (C) Scanning electron microscopy in one and 12 months SAMP8 mice. Few OHCs are lacking (asterisks) among the three rows, but all IHCs are present at 1 month. The higher magnification insert shows an OHC stereociliary bundle with missing sterocilia (arrow). In a 12-month-old mouse, all OHCs and numerous IHCs (asterisks) have disappeared. The white box indicates a damaged IHC stereociliary bundle. In the insert, enlargement of the same IHC stereociliary bundle shows fused stereocilia. Scale bar = 10 µm; Insert in (A) = 1 µm. (D) Electron transmission microscopy of the stria vascularis. At one month, the three layers of strial cells, marginal (Mc), intermediate (Ic), basal (Bc) cells, and the blood vessels (Vx) appear normal. At 12 months, enlarged intercellular spaces and perivascular edema (asterisks) are seen. Scale bar = 10 µm. (E) Light microscopical evaluation of spiral ganglion loss. Shown is the normal aspect and density of neurons at 1 month, and a reduced number of spiral ganglion neurons at 12 months. Scale bar = 50 µm. (Adapted from Ménardo et al., [<a href="#B59-jcm-09-00218" class="html-bibr">59</a>]). Full article ">Figure 5
Pharmacological mitigation of ROS prevents loss of hearing and hair cells in SAMP8 mice (A) SAMP8 mice and EUK-207. Shown are a SAMP8 mouse aged six months and the synthetic superoxide dismutase/catalase mimetic EUK-207. (B) Physiological assessment. The auditory brainstem response (ABR) thresholds recorded before (pale red plot) and after two months (pink plot) and three months (red plot) of Manitol treatments, or before (pale blue plot) and after two months (azure plot) and three months (blue plot) of EUK-207 (10 µM) treatments. (C) Morphological assessment. Representative scanning electron micrographs showing the basal regions of cochleae from Manitol-treated (left panel) and EUK-207-treated (right panel) SAMP8 mice after three months. Scale bar = 15 µm (Adapted from Benkafadar et al. [<a href="#B70-jcm-09-00218" class="html-bibr">70</a>]). Full article ">

Other

Jump to: Research, Review

15 pages, 1142 KiB

Open AccessOpinion

Musical Training for Auditory Rehabilitation in Hearing Loss

by Jacques Pesnot Lerousseau, Céline Hidalgo and Daniele Schön

J. Clin. Med. 2020, 9(4), 1058; https://doi.org/10.3390/jcm9041058 - 8 Apr 2020

Cited by 11 | Viewed by 5374

Abstract

Despite the overall success of cochlear implantation, language outcomes remain suboptimal and subject to large inter-individual variability. Early auditory rehabilitation techniques have mostly focused on low-level sensory abilities. However, a new body of literature suggests that cognitive operations are critical for auditory perception [...] Read more.

Despite the overall success of cochlear implantation, language outcomes remain suboptimal and subject to large inter-individual variability. Early auditory rehabilitation techniques have mostly focused on low-level sensory abilities. However, a new body of literature suggests that cognitive operations are critical for auditory perception remediation. We argue in this paper that musical training is a particularly appealing candidate for such therapies, as it involves highly relevant cognitive abilities, such as temporal predictions, hierarchical processing, and auditory-motor interactions. We review recent studies demonstrating that music can enhance both language perception and production at multiple levels, from syllable processing to turn-taking in natural conversation. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

15 pages, 1407 KiB

Open AccessPerspective

Contemporary Speech and Oral Language Care for Deaf and Hard-of-Hearing Children Using Hearing Devices

by François Bergeron, Aurore Berland, Dominique Demers and Suzie Gobeil

J. Clin. Med. 2020, 9(2), 378; https://doi.org/10.3390/jcm9020378 - 30 Jan 2020

Cited by 9 | Viewed by 6118

Abstract

Contemporary speech and language interventions are not limited to disabilities but embrace the pragmatics of communication behaviors from the perspective of functional social participation. Accordingly, current speech and language therapies for deaf and hard-of-hearing children include a broad spectrum of approaches and techniques. [...] Read more.

Contemporary speech and language interventions are not limited to disabilities but embrace the pragmatics of communication behaviors from the perspective of functional social participation. Accordingly, current speech and language therapies for deaf and hard-of-hearing children include a broad spectrum of approaches and techniques. This paper explores contemporary approaches and techniques for speech and oral language interventions for deaf and hard-of-hearing children using hearing devices, evidence of efficacy and how they are implemented in diverse clinical practices. Full article

(This article belongs to the Special Issue Therapies for Hearing Loss)

► Show Figures

Figure 1

Journal Menu

Journal Browser

Therapies for Hearing Loss

Share This Special Issue

Special Issue Editor

Special Issue Information

Keywords

Benefits of Publishing in a Special Issue

Published Papers (18 papers)

Research

Review

Other

Further Information

Guidelines

MDPI Initiatives

Follow MDPI